NEW YORK (GenomeWeb) – Liquid biopsy developer Angle announced today that it has raised £2.8 million ($3.7 million) through a subscription for approximately 7.5 million new ordinary shares at 37.5 pence each.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.